Particulars |
Company Name |
Piramal Pharma Ltd |
Year End |
202403 |
Full Year |
Equity (Rs Cr.) |
1,325.75 |
B.V. Rs |
52.90 |
Sales Rs Cr. |
4,390.11 |
NP Rs Cr. |
387.88 |
NP Var% |
434.00 |
Div% |
1.00 |
CPS Rs |
4.50 |
EPS Rs |
2.90 |
Traded Value(Rs Lakhs) |
403.89 |
52 Week High |
308.00 |
52 Week Low |
136.00 |
Price BSE |
206.00 |
Price NSE |
206.00 |
Market Capital(Rs Cr.) |
27,310.41 |
P/C Ratio |
46.00 |
P/E Ratio |
70.40 |
Price Vs.BV |
3.89 |
|
Latest Quarter |
Year End |
202412 |
Sales Rs Cr. |
1,248.32 |
NP Rs Cr. |
118.80 |
NP Var % |
60.00 |
Trailing Twelve Months |
Year End |
202412 |
Sales |
4,897.03 |
OPM |
18.78 |
NP |
642.75 |
NP Var% |
329.94 |
EPS |
5.18 |
PE |
39.77 |
|
|